Intriguingly, the majority of CD8+ T cells in the bone marrow of AML patients expressed Siglec-7, with high co-expression of CTLA4, but lower expression of other inhibitory receptors (PD1, LAG3, BTLA, TIM3). The gene discussed is HAVCR2; the disease is acute myeloid leukemia.